FDA Approves Golimumab for Patients with pJIA & Psoriatic Arthritis
Space & Other Races
FDA Approves Tofacitinib for Young Patients with Active Polyarticular JIA
FDA Updates Boxed Warning of Benzodiazepines, Adding Risks for Abuse & Addiction
Janus Kinase vs. TNF Inhibitors: The Context for Venous Thromboembolism Risk with RA Treatments
Nerve Growth Factor Inhibitor Study Highlights Promise as an OA Pain Treatment
RA Patients Taking Either 15 mg or 30 mg Dose of Upadacitinib Experience Improvement
Oxford University to Study Adalimumab as Potential COVID-19 Treatment
FDA Receives Upadacitinib Application for Ankylosing Spondylitis & Approves Tramadol Hydrochloride Oral Solution
- 1
- 2
- 3
- …
- 107
- Next Page »